GENERAL CARDIOLOGY: Management of pericardial effusion

Soler‐Soler, Jordi; Sagristà-Sauleda, Jaume; Permanyer-Miralda, Gaietà

doi:10.1136/heart.86.2.235

Cited by 79 publications

(32 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most commonly, bloody pericardial effusion is associated with myocardial infarction, malignant diseases, or tuberculosis (1,2,5,8,9). In the present case no evidence of malignant tumor or tuberculosis was observed.…”

Section: Discussionsupporting

confidence: 44%

See 1 more Smart Citation

A Patient with Graves' Disease Accompanied by Bloody Pericardial Effusion

et al. 2005

View full text Add to dashboard Cite

A hyperthyroid patient with bloody pericardial effusion is presented. He was hospitalized for severe dyspnea. Pericardiocentesis yielded 1.2 liters of bloody fluid. Biochemical, cytologic, and radiologic examinations failed to identify the etiology of the effusion. Upon normalization of thyroid function using antithyroid drugs, the pericardial effusion resolved without recurrence. The patient was diagnosed as Graves' disease, which rarely is complicated by bloody pericardial effusion. As it is rarely reported and not widely known, this association may be underdiagnosed. (Internal Medicine 44: 1064-1068, 2005)

show abstract

Section: Discussionsupporting

confidence: 44%

“…Pericardial effusion is the most frequent manifestation of pericarditis, which has variety of causes (1,2). Noninfectious causes include autoimmune, neoplastic, and metabolic diseases, as well as trauma (3).…”

Section: Introductionmentioning

confidence: 99%

A Patient with Graves' Disease Accompanied by Bloody Pericardial Effusion

et al. 2005

View full text Add to dashboard Cite

show abstract

“…We had no evidence for the more common chronic pericardial effusion causes, such as neoplasia, uremia, postmyocardial infarction, viral infection, collagen vascular disease, or tuberculosis. 6 Large pericardial effusions are commonly chronic and idiopathic. We speculated that the effusion was secondary to CHF rather than the cause of volume retention.…”

Section: Pericardial and Restrictive Cardiac Diseasementioning

confidence: 99%

Obesity and Hypertension-Induced Restrictive Cardiomyopathy

et al. 2004

View full text Add to dashboard Cite

“…Moreover, the causes of PE have changed over time, 5 and the causes and the prognosis of PE may be different according to region, economic state, and hospital. 3 We undertook this study to evaluate the etiology, clinical outcome, and prognosis of patients with large, symptomatic PE treated by echo-guided pericardiocentesis.…”

Section: Introductionmentioning

confidence: 99%

Prognosis of Large, Symptomatic Pericardial Effusion Treated by Echo‐guided Percutaneous Pericardiocentesis

Kil

Jung

Koh

et al. 2008

Clinical Cardiology

View full text Add to dashboard Cite

Backgrounds:The causes and prognosis of pericardial effusion (PE) may be different according to time, region, economy, and hospital. This study was performed to evaluate the etiology, clinical outcome, and prognosis of patients with large, symptomatic PE treated by echo-guided pericardiocentesis at Kangnam St. Mary's Hopital (the Catholic University of Korea, Seoul, Korea). Hypothesis: According to etiologies of large, symptomatic PE, the prognosis of patients may be different. Methods: We reviewed 116 consecutive patients who underwent echo-guided pericardiocentesis due to large, symptomatic PE over the last 12 y. The Kaplan-Meier survival curve with log-rank method was applied for the survival analysis.Results: Procedural success rate of echo-guided pericardiocentesis was 99.1%. Common causes of PE requiring pericardiocentesis were lung cancer (27.6%), tuberculosis (TB) (13.8%), and uremia (6.9%). The mortality rate of 6 mo after the pericardiocentesis was 80.3% in malignant PE, whereas the over-all mortality rate was 18.2% in nonmalignant PE (p<0.0001). Among the malignant PE, lung cancer (27.6%) and breast cancers (6.9%) were the most common causes. The mean cytologic detection rate and mean life expectancy of malignant PE were 44% and 5-7 mo. Patients with breast cancer and lymphoma had relatively better life expectancy (11.4 and 7.7 mo), whereas those with stomach cancer and metastases of unknown origin (MUO) had poorer prognosis (1.2 and 2.3 mo). The most common causes of nonmalignant PE were TB, uremia, and iatrogenic, and their mean life expectancy was approximately 54 mo. Conclusions: Malignancy, especially lung cancer and TB, were the most common causes of large symptomatic PE. The prognosis of large symptomatic PE was related to the underlying disease. Malignant PE was associated with the poorest prognosis.

show abstract

GENERAL CARDIOLOGY: Management of pericardial effusion

Cited by 79 publications

References 25 publications

A Patient with Graves' Disease Accompanied by Bloody Pericardial Effusion

A Patient with Graves' Disease Accompanied by Bloody Pericardial Effusion

Obesity and Hypertension-Induced Restrictive Cardiomyopathy

Prognosis of Large, Symptomatic Pericardial Effusion Treated by Echo‐guided Percutaneous Pericardiocentesis

Contact Info

Product

Resources

About